New USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to Create National Momentum
Open accessAbstract
Li Wang, PhD; Xiaoguang Li, PhD; Zhaoxin Wang, PhD; Michael P. Bancks, PhD; Mercedes R. Carnethon, PhD; Philip Greenland, MD; Ying-Qing Feng, MD; Hui Wang, MD, PhD; Victor W. Zhong, PhD
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The most recent US Preventive Services Task Force Recommendation Statement and updated Evidence Review have added metformin among diabetes prevention interventions.
“The most recent US Preventive Services Task Force Recommendation Statement and updated Evidence Review have added metformin among diabetes prevention interventions. 13,17,18”
From Metformin Prescription Rates for Patients with Prediabetes (2022) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2021</i>
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972 · see citing works
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480 · see citing works
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2345 · Cited by 319 · see citing works
Reach and use of diabetes prevention services in the United States, 2016-2017.
Ali, M. K., McKeever Bullard, K., Imperatore, G., Benoit, S. R., Rolka, D. B., Albright, A. L., & Gregg, E. W. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3160 · Cited by 153 · see citing works
Self-citationZhang, X., Devlin, H. M., Smith, B., Imperatore, G., Thomas, W., Lobelo, F., Ali, M. K., Norris, K., Gruss, S., Bardenheier, B., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176436 · Cited by 110 · see citing works
Self-citationJonas, D. E., Crotty, K., Yun, J. D. Y., Middleton, J. C., Feltner, C., Taylor-Phillips, S., Barclay, C., Dotson, A., Baker, C., Balio, C. P., et al. (2021) · JAMA · doi:10.1001/jama.2021.10403 · Cited by 96 · see citing works
Griffin, S. J., Rutten, G. E. H. M., Khunti, K., Witte, D. R., Lauritzen, T., Sharp, S. J., Dalsgaard, E.-M., Davies, M. J., Irving, G. J., Vos, R. C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30349-3 · Cited by 55 · see citing works
Flagged first, then by citations
Research works printed but not linked: 9
- Wang L, Li X, Wang Z, et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018. JAMA. Published online June 25, 2021. doi:10.1001/jama.2021.9883 · DOI
- N Engl J Med. 2021;384(23):2219-2228. doi:10.1056/NEJMsa2032271 · DOI · Paper page
- Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012; 380(9855):1741-1748. doi:10.1016/S0140-6736(12) 61422-6 · DOI
- Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589. doi:10.1056/ NEJMoa0806470 · DOI · Paper page
- Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC's National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331-1341. doi: 10.2337/dc16-2099 · DOI · Paper page
- Valabhji J, Barron E, Bradley D, et al. Early outcomes from the English National Health Service Diabetes Prevention Programme. Diabetes Care. 2020;43(1):152-160. doi:10.2337/dc19-1425 · DOI · Paper page
- Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications. JAMA. 2019;321 (19):1867-1868. doi:10.1001/jama.2019.3471 · DOI
- Zhou X, Siegel KR, Ng BP, et al. Cost-effectiveness of diabetes prevention interventions targeting high-risk individuals and whole populations: a systematic review. Diabetes Care. 2020;43(7):1593-1616. doi:10.2337/dci20-0018 · DOI · Paper page
- Moin T, Li J, Duru OK, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542-548. doi:10.7326/ M14-1773 · DOI · Paper page
Cited by
Sorted by citations
Metformin Prescription Rates for Patients with Prediabetes
Hughes, A., Khan, T., Kirley, K., Moin, T., Mainous, A., Sachdev, N., Williams, J., & Wozniak, G. (2022) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2022.04.210485 · Cited by 15 · see citing works
Self-citation
- Authors
- Gregg, E. W., & Moin, T.
- Affiliations
- Imperial College London (GB)
- University of California, Los Angeles (US)
- Corresponding author
- Gregg, Edward W.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-08-24
- Volume
- 326
- Issue
- 8
- Pages
- 701
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3193355925
- Cited by
- 9
- References
- 7
- Citations by year
- 2025: 2 · 2023: 5 · 2022: 1 · 2021: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124503)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, type 2 diabetes, diabetes screening, USPSTF recommendations, screening guidelines, glycemic testing
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Mass Screening, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
